Skip to main content
BMGL
NASDAQ Industrial Applications And Services

Basel Medical FY2026: Revenue Up 45% to S$16.4M, But Material Weakness and Going-Concern Dependency Disclosed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$4.99
Mkt Cap
$37.835M
52W Low
$2.56
52W High
$19.92
52W Position info
95% above low
Off High info
75% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

BMGL sits 95% above its 52-week low of $2.56.

Summary

Basel Medical's FY2026 20-F shows revenue up 45.2% to S$16.4 million and a much smaller loss, but cash is down to S$0.53 million, going concern depends on shareholder support and new financing, and management disclosed a material weakness in internal controls.


Key Events · Earnings and Guidance · BMGL

  • FY2026 Revenue Jumps 45.2%

    Revenue rose to S$16,441,770 (US$12,808,828) from S$11,319,944, driven by higher business activity and demand for the group's clinic services.

  • Loss Narrows on Goodwill Base Effect

    Loss before tax fell to S$1,249,833 (US$973,673) from S$11,053,571, a year that carried a S$10,349,252 full goodwill impairment on the Bethesda acquisition; FY2026 had no such charge.

  • Cash Drops to S$0.53 Million

    Cash and cash equivalents fell to S$529,887 (US$409,464) from S$3,044,466, with S$635,207 used in operating activities and S$2,868,009 paid on lease principal.

  • Going Concern Rests on Outside Support

    The filing states continuation as a going concern depends on the major shareholder's financial support, sustainable operating cash flows over the next 12 months, and the ability to procure additional financing.


Analysis · BMGL · Industrial Applications And Services

Revenue grew 45.2% to S$16.44 million and the loss before tax narrowed to S$1.25 million from S$11.05 million — but last year's number was dominated by a S$10.35 million goodwill write-off on the Bethesda acquisition, so the improvement is mostly the absence of that charge rather than an operating turnaround. The bigger issue is the balance sheet: cash fell to S$0.53 million from S$3.04 million, operating activities burned S$0.64 million, and the company states its going-concern basis depends on its major shareholder's support, sustainable cash generation, and its ability to raise more financing. Management also disclosed a material weakness in internal control over financial reporting tied to insufficient IFRS-skilled staff and concluded disclosure controls were not effective at June 30, 2026. The October 2026 raise (US$7.98 million gross, ~US$7.42 million net) is what keeps the lights on near term, and the filing flags that the 6 million common warrants — exercisable on a zero-cash basis — would substantially dilute holders if used.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BMGL was trading at $4.99 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $37.8M. The 52-week trading range was $2.56 to $19.92. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BMGL - Latest Insights

BMGL
Oct 08, 2026, 4:46 PM EDT
Filing Type: 424B4
Importance Score:
8
Price at Filing: $3.65
Real-time Price: $0.470 info
Change: -$3.18 (-87%) info
Market Cap: $6.384M info
BMGL
Sep 23, 2026, 4:06 PM EDT
Filing Type: F-1/A
Importance Score:
8
Price at Filing: $4.09
Real-time Price: $0.470 info
Change: -$3.62 (-89%) info
Market Cap: $6.384M info
BMGL
Sep 17, 2026, 4:12 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.31
Real-time Price: $0.470 info
Change: -$3.84 (-89%) info
Market Cap: $6.384M info
BMGL
Sep 17, 2026, 4:06 PM EDT
Filing Type: F-1
Importance Score:
8
Price at Filing: $4.31
Real-time Price: $0.470 info
Change: -$3.84 (-89%) info
Market Cap: $6.384M info
BMGL
Aug 10, 2026, 6:30 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.70
Real-time Price: $0.470 info
Change: -$5.23 (-92%) info
Market Cap: $6.384M info